EcoR1 Capital, LLC sold ADAP

July 29, 2025 · Form 4 insider transaction

EcoR1 Capital, LLC sold 2,687,460 shares of ADAPTIMMUNE THERAPEUTICS PLC at $0.10 per share, a transaction worth $272.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
2,687,460
Price
$0.10
Total value
$272.0K
Role
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJuly 29, 2025
Filing dateJuly 30, 2025
Shares owned after127,805,220
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

These Ordinary Shares are held through American Depositary Shares ("ADS") of the Issuer. Each ADS represents 6 Ordinary Shares.; The reporting persons sold 447,910 ADSs representing 2,687,460 Ordinary Shares. Qualified Fund sold 418,303 of those ADSs, representing 2,509,818 Ordinary Shares.; The price reported in Column 4 is the price per ADS sold by the reporting persons.; After this transaction, the reporting persons beneficially owned 21,300,870 ADSs, including 20,151,331 ADSs held by Qualified Fund representing 120,907,986 Ordinary Shares.; The reporting persons are EcoR1 Capital, LLC ("Ecor1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Fund"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.

View the original Form 4 on SEC EDGAR